Conference
A comparison of combined immune checkpoint inhibitors (IO) versus vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) in the treatment of advanced clear cell renal cell carcinoma
Authors
Chan AS; Pond GR; Sonpavde G; Alva AS
Volume
38
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
February 20, 2020
Name of conference
Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
CA, San Francisco
Conference start date
February 13, 2020
Conference end date
February 15, 2020
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
6
ISSN
0732-183X